Clinical trial
The Impact of Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex at Different Intensities and Frequencies on Cognition of Schizophrenic Patients
NCT05342727 is registered in ClinicalTrials.gov with The National Brain Mapping Laboratory (NBML) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex at Different Intensities and Frequencies on Cognition of Schizophrenic Patients
- Lead sponsor
- The National Brain Mapping Laboratory (NBML)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- July 31, 2022
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.